Form 4: Director Michael Ellenbogen Trades Evolv Technologies Stock

Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. Class A Common Stock and stock options on May 15, 2026, executed under a Rule 10b5-1 trading plan.

Summary

• Michael Ellenbogen, a Director at Evolv Technologies Holdings, Inc. (EVLV), reported several transactions on May 15, 2026.
• He acquired 80,745 shares of Class A Common Stock at a price of $0.24 per share.
• Concurrently, he disposed of 80,745 shares of Class A Common Stock at a weighted average price of $5.63, with individual sales ranging from $5.53 to $5.77.
• Following these transactions, Ellenbogen beneficially owns 2,083,961 shares of Class A Common Stock directly.
• An additional 151,135 shares are held indirectly by Family Horizon Trust.
• The disposed shares were part of a Rule 10b5-1 trading plan initiated on June 12, 2025.
• Ellenbogen also exercised a stock option to acquire 80,745 shares of Class A Common Stock at an exercise price of $0.24 per share, with the option expiring on September 13, 2027.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the significant sale of shares by a director, despite being executed under a pre-planned trading strategy.

Positives

• Acquisition of 80,745 shares of Class A Common Stock at a low price of $0.24 per share.
• Exercise of stock options, indicating potential for future gains if the stock price increases.
• The transactions were conducted under a Rule 10b5-1 trading plan, suggesting pre-planned and potentially less market-impactful sales.

Negatives

• Disposal of 80,745 shares of Class A Common Stock at a significantly higher price ($5.53-$5.77) than the acquisition price ($0.24), indicating a sale of appreciated assets.
• The weighted average sale price of $5.63 is considerably higher than the acquisition price of $0.24 for the same number of shares, suggesting a profitable exit for a portion of holdings.

Risks

• The disposal of a significant number of shares, even under a pre-planned trading strategy, could be interpreted by the market as a lack of confidence by a key insider.
• The stock price range of sales ($5.53 to $5.77) indicates a potential peak or high point in the stock's recent trading, and future performance may not sustain these levels.

Future Outlook

The filing does not contain forward-looking statements or guidance. The transactions are historical events reported for transparency.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
• The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by the market. While this filing details a pre-planned sale under a Rule 10b5-1, the disposal of a significant number of shares by a director can still influence investor sentiment, especially in a volatile market or for a company with a smaller market capitalization.

Stakeholder Impact

• Shareholders: May interpret the sale of shares by a director as a bearish signal, potentially impacting stock price. However, the Rule 10b5-1 plan mitigates concerns about opportunistic selling.
• Management: The transactions are by a director, indicating a personal financial decision rather than a company-wide strategic move.
• Creditors: No direct impact from this filing.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan.
• The company may provide further disclosures if additional insider transactions occur.

Key Dates

Recommendation

The filing reports a director's pre-planned sale of stock. While sales by insiders can be a negative signal, the execution under a Rule 10b5-1 plan suggests a predetermined strategy rather than a reaction to current negative information. The acquisition of shares at a low price and exercise of options are positive, but the net effect on the stock price is uncertain without further context on the company's performance and future prospects. Therefore, a 'hold' recommendation is appropriate pending more comprehensive financial and strategic updates.

Keywords

Evolv Technologies Holdings, EVLV, Form 4, Insider Trading, Stock Transaction, Class A Common Stock, Stock Options, Rule 10b5-1, Director Transactions, Beneficial Ownership